Simulated rat intestinal fluid improves oral exposure prediction for poorly soluble compounds over a wide dose rangeReportar como inadecuado




Simulated rat intestinal fluid improves oral exposure prediction for poorly soluble compounds over a wide dose range - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

ADMET and DMPK, Vol.4 No.1 March 2016. -

Solubility can be the absorption limiting factor for drug candidates and is therefore a very important input parameter for oral exposure prediction of compounds with limited solubility. Biorelevant media of the fasted and fed state have been published for humans, as well as for dogs in the fasted state. In a drug discovery environment, rodents are the most common animal model to assess the oral exposure of drug candidates. In this study a rat simulated intestinal fluid rSIF is proposed as a more physiologically relevant media to describe drug solubility in rats. Equilibrium solubility in this medium was tested as input parameter for physiologically-based pharmacokinetics PBPK simulations of oral pharmacokinetics in the rat. Simulations were compared to those obtained using other solubility values as input parameters, like buffer at pH 6.8, human simulated intestinal fluid and a comprehensive dissolution assay based on rSIF. Our study on nine different compounds demonstrates that the incorporation of rSIF equilibrium solubility values into PBPK models of oral drug exposure can significantly improve the reliability of simulations in rats for doses up to 300 mg-kg compared to other media. The comprehensive dissolution assay may help to improve further simulation outcome, but the greater experimental effort as compared to equilibrium solubility may limit its use in a drug discovery environment. Overall, PBPK simulations based on solubility in the proposed rSIF medium can improve prioritizing compounds in drug discovery as well as planning dose escalation studies, e.g. during toxicological investigations.

Computational ADME; preclinical pharmacokinetics; PBPK; modelling; solubility



Autor: Jörg Berghausen - ; Novartis Institutes for Biomedical Research, Novartis Campus, CH-4002 Basel Frank H. Seiler - ; Chemical and

Fuente: http://hrcak.srce.hr/



DESCARGAR PDF




Documentos relacionados